MontiFast
Montelukast
Presentation:
MontiFast 4 mg Chewable Tablet: Each chewable tablet contains Montelukast Sodium INN equivalent to Montelukast 4 mg.
MontiFast 5 mg Tablet: Each film-coated tablet contains Montelukast Sodium INN equivalent to Montelukast 5 mg.
MontiFast 10 mg Tablet: Each film-coated tablet contains Montelukast Sodium INN equivalent to Montelukast 10 mg.
Description
Mointifast is indicated for the prevention and chronic treatment of asthma in adults and pediatric patients from 12 months of age and older. It can be used for the prophylaxis of exercise-induced bronchoconstriction in patients from 2 years of age and older. Montifast is also indicated for the symptomatic relief of allergic rhinitis (seasonal and perennial allergic rhinitis) in adults and pediatric patients from 2 years of age and older.
Therapeutic Class: Antiasthmatic, Cysteinyl Leukotriene Receptor Antagonist.
